DrugPatentWatch Database Updates: New Patent Delistings
✉ Email this page to a colleague
DrugPatentWatch Database Updates: New Patent Delistings
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Patent Expiration | Usecode | Patented / Exclusive Use |
---|---|---|---|---|---|---|---|---|---|---|---|
Glaxo Grp England | INCRUSE ELLIPTA | umeclidinium bromide | POWDER | 205382 | Apr 30, 2014 | RX | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||
Glaxo Grp England | INCRUSE ELLIPTA | umeclidinium bromide | POWDER | 205382 | Apr 30, 2014 | RX | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||
Glaxo Grp England | INCRUSE ELLIPTA | umeclidinium bromide | POWDER | 205382 | Apr 30, 2014 | RX | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Type | >RLD | >Patent No. | >Patent Expiration | >Usecode | >Patented / Exclusive Use |